BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2023 6:13:55 AM | Browse: 69 | Download: 274
Publication Name World Journal of Diabetes
Manuscript ID 84803
Country China
Received
2023-03-28 12:32
Peer-Review Started
2023-03-28 12:32
To Make the First Decision
Return for Revision
2023-07-04 06:54
Revised
2023-07-11 14:47
Second Decision
2023-07-31 03:05
Accepted by Journal Editor-in-Chief
2023-08-04 05:20
Accepted by Company Editor-in-Chief
2023-09-06 08:02
Articles in Press
2023-09-06 08:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-09-28 03:09
Publish the Manuscript Online
2023-11-14 06:13
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Basic Study
Article Title Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion
Manuscript Source Unsolicited Manuscript
All Author List Yu-Qi Li, Lu-Yang Zhang, Yu-Chi Zhao, Fang Xu, Zhi-Yong Hu, Qi-Hao Wu, Wen-Hao Li and Ya-Nuo Li
ORCID
Author(s) ORCID Number
Yu-Qi Li http://orcid.org/0000-0003-0236-8581
Lu-Yang Zhang http://orcid.org/0009-0003-7813-0024
Yu-Chi Zhao http://orcid.org/0000-0002-4776-1419
Fang Xu http://orcid.org/0000-0002-2725-8533
Zhi-Yong Hu http://orcid.org/0000-0001-6855-2838
Qi-Hao Wu http://orcid.org/0009-0006-7709-6313
Wen-Hao Li http://orcid.org/0009-0001-8920-2455
Ya-Nuo Li http://orcid.org/0000-0002-6441-5024
Funding Agency and Grant Number
Funding Agency Grant Number
The National Natural Science Foundation of China 31771284
The Basic Research Project of Yantai Science and Technology Innovation and Development Plan 2022JCYJ026
The Natural Science Foundation of Shandong province ZR202111250163
Yantai Science and Technology Plan Project 2022YD062
Corresponding Author Ya-Nuo Li, PhD, Professor, Department of Pathophysiology, School of Basic Medicine, Binzhou Medical University, No. 346 Guanhai Road, Laishan District, Yantai 264000, Shandong Province, China. liyanuo@bzmc.edu.cn
Key Words Vascular endothelial growth factor B; Insulin-mediated; Glucagon secretion; Prediabetes; Impaired glucose tolerance
Core Tip Impaired glucose tolerance (IGT) is an abnormal metabolic stage between the normal state and diabetes, which belongs to prediabetes. Therefore, intervention in IGT can effectively reduce the incidence rate of diabetes. The pathological mechanism of IGT is related to glucose homeostasis imbalance and decreased insulin sensitivity. Currently, vascular endothelial growth factor B (VEGFB) has been reported to have the effect of restoring glucose tolerance and improving insulin sensitivity. Therefore, the use of VEGFB as a target for intervention has become the focus of current research. This research mainly illustrates the role of VEGFB in promoting insulin and glucagon secretion to alleviate IGT and its potential molecular mechanism.
Publish Date 2023-11-14 06:13
Citation Li YQ, Zhang LY, Zhao YC, Xu F, Hu ZY, Wu QH, Li WH, Li YN. Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion. World J Diabetes 2023; 14(11): 1643-1658
URL https://www.wjgnet.com/1948-9358/full/v14/i11/1643.htm
DOI https://dx.doi.org/10.4239/wjd.v14.i11.1643
Full Article (PDF) WJD-14-1643-with-cover.pdf
Full Article (Word) WJD-14-1643.docx
Manuscript File 84803_Auto_Edited-JLW.docx
Answering Reviewers 84803-Answering reviewers.pdf
Audio Core Tip 84803-Audio core tip.m4a
Biostatistics Review Certificate 84803-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 84803-Conflict-of-interest statement.pdf
Copyright License Agreement 84803-Copyright license agreement.pdf
Institutional Animal Care and Use Committee Approval Form or Document 84803-Institutional animal care and use committee statement.pdf
Non-Native Speakers of English Editing Certificate 84803-Language certificate.pdf
Peer-review Report 84803-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 84803-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 84803-Bing-Chen YL-2.png
Scientific Editor Work List 84803-Scientific editor work list.pdf